Cipla Suspends Effort To Buy Majority Of South Africa's Cipla Medpro
This article was originally published in PharmAsia News
Cipla has suspended its effort to buy a majority stake in the South Africa drug maker Cipla Medpro that shares its name, citing issues concerning its valuation.
You may also be interested in...
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.